Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiation-Sensitizing Agents | 2 | 2021 | 358 | 0.720 |
Why?
|
| Klinefelter Syndrome | 1 | 2019 | 49 | 0.690 |
Why?
|
| Genes, Recessive | 1 | 2022 | 643 | 0.680 |
Why?
|
| Urban Health Services | 1 | 2019 | 179 | 0.620 |
Why?
|
| DNA Damage | 3 | 2021 | 2432 | 0.510 |
Why?
|
| DNA Repair | 2 | 2021 | 2046 | 0.430 |
Why?
|
| Hypoglycemia | 1 | 2019 | 861 | 0.400 |
Why?
|
| Emergency Medical Services | 2 | 2019 | 1916 | 0.370 |
Why?
|
| Phthalazines | 3 | 2021 | 363 | 0.370 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2022 | 11732 | 0.330 |
Why?
|
| Germinal Center | 1 | 2011 | 377 | 0.310 |
Why?
|
| Hypoglycemic Agents | 1 | 2018 | 2875 | 0.280 |
Why?
|
| Genome-Wide Association Study | 2 | 2022 | 12264 | 0.270 |
Why?
|
| Insulin | 2 | 2021 | 6583 | 0.250 |
Why?
|
| Blood Glucose | 1 | 2018 | 6259 | 0.240 |
Why?
|
| Lung Neoplasms | 3 | 2021 | 13096 | 0.210 |
Why?
|
| Piperazines | 3 | 2021 | 2491 | 0.210 |
Why?
|
| Cyclin C | 1 | 2021 | 14 | 0.210 |
Why?
|
| Cyclin-Dependent Kinase 8 | 1 | 2021 | 52 | 0.200 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7281 | 0.200 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2022 | 17449 | 0.190 |
Why?
|
| Diabetes Mellitus | 1 | 2018 | 5755 | 0.180 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2020 | 114 | 0.180 |
Why?
|
| Hyperuricemia | 1 | 2021 | 211 | 0.160 |
Why?
|
| Cell Movement | 1 | 2011 | 5216 | 0.160 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 13668 | 0.160 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2021 | 5529 | 0.150 |
Why?
|
| Sensory System Agents | 1 | 2017 | 23 | 0.150 |
Why?
|
| B-Lymphocytes | 1 | 2011 | 4665 | 0.150 |
Why?
|
| Homozygote | 1 | 2022 | 1786 | 0.150 |
Why?
|
| Restraint, Physical | 1 | 2018 | 193 | 0.140 |
Why?
|
| Haloperidol | 1 | 2018 | 397 | 0.140 |
Why?
|
| Standard of Care | 1 | 2020 | 564 | 0.140 |
Why?
|
| Insulin Resistance | 2 | 2021 | 3863 | 0.140 |
Why?
|
| Capsaicin | 1 | 2017 | 231 | 0.140 |
Why?
|
| Quinolines | 1 | 2021 | 730 | 0.140 |
Why?
|
| Uric Acid | 1 | 2021 | 765 | 0.130 |
Why?
|
| Antiemetics | 1 | 2017 | 176 | 0.130 |
Why?
|
| Metabolome | 1 | 2022 | 895 | 0.130 |
Why?
|
| Europe | 1 | 2022 | 3339 | 0.130 |
Why?
|
| Gene Frequency | 1 | 2022 | 3588 | 0.130 |
Why?
|
| Nausea | 1 | 2017 | 668 | 0.120 |
Why?
|
| Triglycerides | 1 | 2022 | 2453 | 0.120 |
Why?
|
| Vomiting | 1 | 2017 | 635 | 0.120 |
Why?
|
| Marijuana Smoking | 1 | 2017 | 253 | 0.120 |
Why?
|
| Hormone Replacement Therapy | 1 | 2019 | 744 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 6313 | 0.110 |
Why?
|
| Marijuana Abuse | 1 | 2017 | 403 | 0.110 |
Why?
|
| Ketamine | 1 | 2018 | 500 | 0.110 |
Why?
|
| Cholesterol, LDL | 1 | 2022 | 2355 | 0.110 |
Why?
|
| Benzodiazepines | 1 | 2018 | 1101 | 0.110 |
Why?
|
| Androgens | 1 | 2019 | 1279 | 0.100 |
Why?
|
| Metformin | 1 | 2018 | 835 | 0.100 |
Why?
|
| Abdominal Pain | 1 | 2017 | 1062 | 0.090 |
Why?
|
| Hypnotics and Sedatives | 1 | 2018 | 1161 | 0.090 |
Why?
|
| Pyridines | 1 | 2021 | 2822 | 0.090 |
Why?
|
| Nuclear Proteins | 2 | 2020 | 5853 | 0.080 |
Why?
|
| Testosterone | 1 | 2019 | 2411 | 0.080 |
Why?
|
| Sex Factors | 1 | 2022 | 10396 | 0.080 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2011 | 548 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2021 | 7723 | 0.070 |
Why?
|
| Recurrence | 1 | 2019 | 8343 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 5169 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2021 | 10480 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 7784 | 0.060 |
Why?
|
| Antigens | 1 | 2011 | 1466 | 0.060 |
Why?
|
| Apoptosis | 1 | 2021 | 9728 | 0.060 |
Why?
|
| Middle Aged | 6 | 2022 | 213367 | 0.060 |
Why?
|
| Male | 7 | 2022 | 350027 | 0.060 |
Why?
|
| Cell Communication | 1 | 2011 | 1621 | 0.060 |
Why?
|
| Humans | 12 | 2022 | 744220 | 0.050 |
Why?
|
| Prevalence | 1 | 2019 | 15226 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 15525 | 0.050 |
Why?
|
| Bovine papillomavirus 1 | 1 | 2000 | 74 | 0.050 |
Why?
|
| Sulfoxides | 1 | 2020 | 48 | 0.050 |
Why?
|
| Adult | 5 | 2022 | 214035 | 0.050 |
Why?
|
| Female | 8 | 2022 | 380197 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11493 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2020 | 553 | 0.040 |
Why?
|
| Hospitalization | 1 | 2018 | 10262 | 0.040 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2000 | 362 | 0.040 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2000 | 442 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2020 | 77426 | 0.040 |
Why?
|
| Genes, p53 | 1 | 2000 | 755 | 0.040 |
Why?
|
| Anesthetics, Dissociative | 1 | 2018 | 80 | 0.040 |
Why?
|
| Thorax | 1 | 2021 | 547 | 0.040 |
Why?
|
| Area Postrema | 1 | 2017 | 7 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 7659 | 0.040 |
Why?
|
| Missouri | 1 | 2017 | 117 | 0.040 |
Why?
|
| Mutation | 1 | 2022 | 29784 | 0.040 |
Why?
|
| Solitary Nucleus | 1 | 2017 | 63 | 0.040 |
Why?
|
| Morpholines | 1 | 2020 | 573 | 0.040 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2021 | 967 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2020 | 1731 | 0.030 |
Why?
|
| TRPV Cation Channels | 1 | 2017 | 236 | 0.030 |
Why?
|
| Young Adult | 2 | 2019 | 56436 | 0.030 |
Why?
|
| Gout | 1 | 2021 | 573 | 0.030 |
Why?
|
| DNA Replication | 1 | 2021 | 1399 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2022 | 2309 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 57768 | 0.030 |
Why?
|
| Mice | 4 | 2021 | 81178 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 20817 | 0.030 |
Why?
|
| Aged | 3 | 2021 | 163253 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 3557 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2021 | 2575 | 0.030 |
Why?
|
| Indoles | 1 | 2020 | 1838 | 0.030 |
Why?
|
| Child | 1 | 2019 | 77679 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 85759 | 0.020 |
Why?
|
| Syndrome | 1 | 2017 | 3250 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2000 | 2924 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2020 | 1940 | 0.020 |
Why?
|
| Animals | 5 | 2021 | 168788 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2020 | 2940 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2021 | 23404 | 0.020 |
Why?
|
| Antipsychotic Agents | 1 | 2018 | 3058 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 16687 | 0.020 |
Why?
|
| Massachusetts | 1 | 2017 | 8663 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2021 | 63119 | 0.010 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 5221 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 21824 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18027 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2017 | 4463 | 0.010 |
Why?
|
| Cell Transformation, Viral | 1 | 2000 | 565 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 39045 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2022 | 53280 | 0.010 |
Why?
|
| Risk Factors | 1 | 2022 | 72280 | 0.010 |
Why?
|
| Cattle | 1 | 2000 | 3922 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2000 | 1782 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2000 | 3001 | 0.010 |
Why?
|
| Cell Line | 1 | 2000 | 15999 | 0.000 |
Why?
|
Concepts
(130)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(19)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_